Just like 2016 and the year before, specialty drugs dominate the 2017 list of top performers in the most recent first year after launch class.
Med Ad News asked Adrienne Morgan and Geetiksa Prasad, the account and copy leads for Ibrance at H4B Chelsea, about their agency’s work with Pfizer’s star breast cancer brand.
The good news … is that innovation is addressing diseases with high-unmet need such as oncology, autoimmune diseases, and central nervous system (CNS) disorders. But, there is a complicating factor in the economic story: the patient population benefiting from launch brands is becoming smaller.
First Year After Launch: New molecular entities launched in the U.S. during 2015 that generated 2016 sales of at least $200 million
A listing of the the new molecular entities launched in the United States during 2015 that generated 2016 sales of at least $200 million
Novo Nordisk and Glooko announced that the new Cornerstones4Care (C4C) Powered by Glooko app is available to help people more effectively manage their diabetes.
South Korea’s Samsung Bioepis started U.S sales of its copy of Johnson & Johnson’s blockbuster rheumatoid arthritis drug Remicade.
Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management
Novo Nordisk and Glooko announced that the new Cornerstones4Care Powered by Glooko app (C4C app) is now available to help people more effectively manage their diabetes.
Support Info-Go, the leading provider of health condition event listings, wants cancer patients to know they are not alone and celebrate independence from their condition with the launch of Cancer-Go.
MedBridge, a developer of patient engagement and clinical education software, has launched MedBridge GO – a patient-facing mobile app designed to improve adherence to clinician-assigned home exercise programs (HEP).
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, announced the ambr 15 automated micro bioreactor system combined with a Nova Biomedical BioProfile FLEX2 automated cell culture analyzer.